Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kushner

Showing results (241-250 of 245) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 245 results.
Pediatric Blood & Cancer|July 5, 2024
Ovarian function in female survivors of high-risk neuroblastomaLauren Jimenez-Kurlander, Amelia DeRosa, Caroline E Kostrzewa, et al.
Plos One|June 6, 2017
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumorsOren J Becher, Nathan E Millard, Shakeel Modak, et al.
Journal of Hematology & Oncology|November 12, 2022
Phase 1 study of intraventricular <sup>131</sup>I-omburtamab targeting B7H3 (CD276)-expressing CNS malignanciesKim Kramer, Neeta Pandit-Taskar, Brian H Kushner, et al.
Nature Genetics|May 11, 2023
Clonal evolution during metastatic spread in high-risk neuroblastomaGunes Gundem, Max F Levine, Stephen S Roberts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2022
Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related LeukemiaBarbara Spitzer, Kayleigh D Rutherford, Gunes Gundem, et al.
Pageof 25

Showing results (241-250 of 245) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 245 results.
Pediatric Blood & Cancer|July 5, 2024
Ovarian function in female survivors of high-risk neuroblastomaLauren Jimenez-Kurlander, Amelia DeRosa, Caroline E Kostrzewa, et al.
Plos One|June 6, 2017
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumorsOren J Becher, Nathan E Millard, Shakeel Modak, et al.
Journal of Hematology & Oncology|November 12, 2022
Phase 1 study of intraventricular <sup>131</sup>I-omburtamab targeting B7H3 (CD276)-expressing CNS malignanciesKim Kramer, Neeta Pandit-Taskar, Brian H Kushner, et al.
Nature Genetics|May 11, 2023
Clonal evolution during metastatic spread in high-risk neuroblastomaGunes Gundem, Max F Levine, Stephen S Roberts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2022
Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related LeukemiaBarbara Spitzer, Kayleigh D Rutherford, Gunes Gundem, et al.
Pageof 25